Join our mailing list!
(Your shopping cart is empty)
Diane Publishing Books
Medicare Part B: Expenditures for New Drugs Concentrated among a Few Drugs, and Most Were Costly for Beneficiaries
James Cosgrove (au)
Some of the drugs approved in recent years by the Department of Health and Human Servicesäó» (HHSäó») Food and Drug Administration (FDA) have been associated with high spending. This report provides information on trends in the costs of newly approved drugs in the Medicare Part B program and the potential implications of these costs for the Medicare program and its beneficiaries. The report (1) describes the drugs newly approved by FDA and paid for by Medicare Part B and compares them to drugs newly approved and not paid for by Part B; and (2) examines, for new Part B drugs, patterns of Medicare expenditures, including overall Part B expenditures and expenditures per beneficiary, and utilization. Tables. This is a print on demand report.
Calendars & Constellations of the Ancient World
Gates of the Alamo
Live Now, Age Later: Proven Ways to Slow Down the Clock
Around the American Table: Treasured Recipes & Food Traditions from the American Cookery Collections of the New York Public Library
Share your knowledge of this product with other customers...
Be the first to write a review
Diane Publishing Co
PO Box 617
Darby, PA 19023-0617
Become an Affiliate
Send Us Feedback
Copyright ï¿½ 2004 Diane Publishing Company. All Rights Reserved.